Long-term fiber tissue remodeling and the progressive thickening of the aortic valve leaflets called calcific aortic stenosis lead to cardiac blood outflow obstruction. This disease is the most prevalent heart valve pathology in developed countries. Surgeons can perform aortic valve replacement through traditional open-heart surgery involving a cut (incision) in the chest or use minimally invasive methods such as transcatheter aortic valve implantation (TAVI). These types of surgery have numerous advantages and limitations. Recently, the Ozaki operation for aortic valve replacement using tissue from the autologous pericardium has been proposed. Despite being a promising technique for aortic valve pathology treatment, there is a lack of long-term results and optimal selection of leaflet sizing. Numerical fluid simulations can help surgeons predict operation outcomes for each patient. Nevertheless, the description of the material model for leaflet mechanics leaves an open question. Furthermore, selecting the most suitable model to describe the different conditions of the aortic valve is difficult. We performed a numerical analysis of aortic valve leaflet material models to describe the hemodynamics in normal, pathological, and Ozaki cases. We also reveal wall shear stress, von Mises stress, and displacement distributions. Based on the parameters mentioned above, we found that the Ozaki case model behaved similarly to the mathematical model describing the normal case. Numerical simulations also provide information on the mechanisms of aortic valve work in different states of the heart cycle.
Hemodynamically significant patent ductus arteriosus (hsPDA) in premature newborns is associated with a risk of PDA-related morbidities. Classification into risk groups may have a clinical utility in cases of suspected hsPDA to decrease the need for echocardiograms and unnecessary treatment. This prospective observational study included 99 premature newborns with extremely low body weight, who had an echocardiogram performed within the first three days of life. Discriminant analysis was utilized to find the best combination of prognostic factors for evaluation of hsPDA. We used binary logistic regression analysis to predict the relationship between parameters and hsPDA. The cohort’s mean and standard deviation gestational age was 27.6 ± 2.55 weeks, the mean birth weight was 1015 ± 274 g. Forty-six (46.4%) infants had a PDA with a mean diameter of 2.78 mm. Median NT-pro-BNP levels were 17,600 pg/mL for infants with a PDA and 2773 pg/mL in the non-hsPDA group. The combination of prognostic factors of hsPDA in newborns of extremely low body weight on the third day of life was determined: NT-pro-BNP, Apgar score, Silverman–Anderson score (Se = 82%, Sp = 88%). A cut-off value of NT-pro-BNP of more than 8500 pg/mL can predict hsPDA (Se = 84%, Sp = 86%).
Currently, aortic valve (AV) disease is the most common reason for heart valve surgery. The gold standard of care for people with aortic pathology is thought to be AV replacement. The issue of prosthesis selection has always been important. Although mechanical prosthesis are robust, lifelong anticoagulation medication is necessary due to the significant risk of thromboembolic consequences. Biological prostheses have a flow structure that is similar to the physiological one, and as malfunction gradually sets in, scheduled recurrent surgery can be carried out. The purpose of this study is to evaluate the short- and long-term effects of biological prosthetic aortic valve replacement (AVR) in elderly individuals. The study included 198 patients with AV pathology [85 men (42.9%)/113 women (57.1%)]. The median age was 70 [66–73] years. There were 175 (88.4%) patients with degenerative AV, 5 (2.5%) with infective endocarditis, and 30 patients (15.2%) had bicuspid AV. The median follow-up period was 26.3±1.4 months. Hospital mortality was 4.5%. No wound complications were detected. Thirty-one patients died in the long-term period. The causes of lethality were: cardiovascular disease (13 patients), malignant neoplasm (5 patients), gastrointestinal disease (2 patients), urinary system disease (1 patient), COVID-19 (1 patient), unknown cause (9 patients). Thus, the five-year postoperative survival rate was 63%, respectively. Throughout the observation period, two patients (2.9%) underwent reoperation on AV. 97.1% of patients were free of reoperation after five years. The five-year survival rate was 63% due to the history of severe concomitant pathology and mean age of the patients of 70 years.